Market Overview:
The global biopharmaceutical CMO services market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for biologics and biosimilars, rising focus on contract manufacturing, and growing investments by pharmaceutical companies in contract manufacturing services. Based on type, the global biopharmaceutical CMO services market is segmented into biologics manufacturing, biosimilars manufacturing, and others. The biosimilars manufacturing segment is expected to grow at a higher rate than other segments during the forecast period. This growth can be attributed to the increasing demand for biosimilars due to their cost-effectiveness as compared to branded drugs. Based on application, the global biopharmaceutical CMO services market is segmented into clinical manufacturing and commercial manufacturing. Clinical Manufacturing includes pre-clinical research activities such as process development & optimization; scale-up; technology transfer; validation studies etc., while Commercial Manufacturing includes filling/packaging of drug products in vials or syringes; labeling operations including batch release testing etc.).
Product Definition:
A biopharmaceutical contract manufacturing organization (CMO) is a company that provides services to help biopharmaceutical companies develop and manufacture their products. These services can include everything from early-stage research and development to full-scale production.
The importance of CMOs lies in their ability to provide a wide range of services that biopharmaceutical companies may not have the resources or expertise to do themselves. This can allow these companies to focus on developing new products while leaving the manufacturing process in the hands of experts.
Biologics Manufacturing:
Biologics manufacturing is the production of biologics including monoclonal antibodies, recombinant proteins, and other complex molecules. The process involves various stages such as upstream processing, fermentation/bioprocessing, purification & concentrating steps along with final packaging.
The global biopharmaceutical CMO services market size was valued at USD 6.5 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period.
Biosimilars Manufacturing:
Biosimilars are biological products that are similar to the molecular structure of an original biologic drug. They have a similar mechanism of action and can be used as a substitute for the original drug. Biosimilars can be manufactured by using either chemical or biological methods. The chemical method involves synthesis while, biological method involves cell culture fermentation & production of proteins in E.coli bacteria cells).
Application Insights:
The others application segment includes research activities, drug discovery and development, and quality control & inspection. The clinical manufacturing segment dominated the global biopharmaceutical CMO services market in 2017 owing to factors such as increasing number of product launches coupled with stringent regulatory requirements for safety.
Clinical manufacturing accounted for a revenue share of over 40% in 2017 due to an increase in the launch of new products coupled with an increase in FDA approvals. For instance, according to IMS Health data published by FDA on September 20th 2018 shows that compared to 2015 there was a rise of around 17% approval rates for novel drugs during that same year which is expected to boost industry growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biopharmaceutical manufacturers coupled with robust R&D infrastructure and high healthcare expenditure levels are some factors attributing to its largest share. Asia Pacific is expected to grow at the fastest CAGR during the forecast period owing to increasing government initiatives for promoting innovation through biotechnology, rising awareness about modern medicines, improving regulatory framework and availability of low-cost labor & raw materials.
The table below provides a detailed analysis of key trends pertaining to regional markets: North America, Europe, Asia Pacific and Rest Of World (RoW). North America held majority revenue share in 2017 due to higher investment by companies as well as higher healthcare expenditure per capita than other regions.
Growth Factors:
- Increasing demand for biopharmaceuticals: The global market for biopharmaceuticals is expected to grow at a CAGR of 10.5% from 2016 to 2021, reaching a value of 2.8 billion by 2021. This growth is primarily attributed to the increasing prevalence of chronic diseases, rising awareness about available treatments, and technological advancements in the field of biotechnology.
- Growing number of approvals for novel drugs: The number of new drug approvals has been on the rise in recent years, with the FDA approving 46 novel drugs in 2016 as against 23 in 2011. This trend is likely to continue over the next few years as well, providing a major boost to the Biopharmaceutical CMO Services market.
- Rising R&D expenditure by pharmaceutical companies: Pharmaceutical companies are increasingly allocating more funds towards R&D activities in order to develop innovative therapies that can address unmet medical needs and improve patient outcomes. As a result, this is likely to lead to an increase in demand for contract manufacturing services over the next few years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Biopharmaceutical CMO Services Market Research Report
By Type
Biologics Manufacturing, Biosimilars Manufacturing, Others
By Application
Clinical Manufacturing, Commercial Manufacturing, Others
By Companies
Lonza, Boehringer Ingelheim, AGC Biologics, Rentschler Biotechnologie, JRS Pharma, Catalent, Biomeva, Samsung BioLogics, AbbVie, Binex, WuXi Biologics, PRA Health Sciences, ProBioGen, KBI Biopharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Biopharmaceutical CMO Services Market Report Segments:
The global Biopharmaceutical CMO Services market is segmented on the basis of:
Types
Biologics Manufacturing, Biosimilars Manufacturing, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Manufacturing, Commercial Manufacturing, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lonza
- Boehringer Ingelheim
- AGC Biologics
- Rentschler Biotechnologie
- JRS Pharma
- Catalent
- Biomeva
- Samsung BioLogics
- AbbVie
- Binex
- WuXi Biologics
- PRA Health Sciences
- ProBioGen
- KBI Biopharma
Highlights of The Biopharmaceutical CMO Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biologics Manufacturing
- Biosimilars Manufacturing
- Others
- By Application:
- Clinical Manufacturing
- Commercial Manufacturing
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biopharmaceutical CMO Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biopharmaceutical CMO Services is a comprehensive marketing and communications services company that helps pharmaceutical companies achieve their business goals. The company offers a variety of services, including market research, public relations, advertising, and branding. It also provides consulting services to help companies develop and implement marketing strategies.
Some of the major companies in the biopharmaceutical cmo services market are Lonza, Boehringer Ingelheim, AGC Biologics, Rentschler Biotechnologie, JRS Pharma, Catalent, Biomeva, Samsung BioLogics, AbbVie, Binex, WuXi Biologics, PRA Health Sciences, ProBioGen, KBI Biopharma.
The biopharmaceutical cmo services market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biopharmaceutical CMO Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biopharmaceutical CMO Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biopharmaceutical CMO Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biopharmaceutical CMO Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biopharmaceutical CMO Services Market Size & Forecast, 2018-2028
4.5.1 Biopharmaceutical CMO Services Market Size and Y-o-Y Growth
4.5.2 Biopharmaceutical CMO Services Market Absolute $ Opportunity
Chapter 5 Global Biopharmaceutical CMO Services Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Biopharmaceutical CMO Services Market Size Forecast by Type
5.2.1 Biologics Manufacturing
5.2.2 Biosimilars Manufacturing
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Biopharmaceutical CMO Services Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Biopharmaceutical CMO Services Market Size Forecast by Applications
6.2.1 Clinical Manufacturing
6.2.2 Commercial Manufacturing
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biopharmaceutical CMO Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biopharmaceutical CMO Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Biopharmaceutical CMO Services Analysis and Forecast
9.1 Introduction
9.2 North America Biopharmaceutical CMO Services Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Biopharmaceutical CMO Services Market Size Forecast by Type
9.6.1 Biologics Manufacturing
9.6.2 Biosimilars Manufacturing
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Biopharmaceutical CMO Services Market Size Forecast by Applications
9.10.1 Clinical Manufacturing
9.10.2 Commercial Manufacturing
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Biopharmaceutical CMO Services Analysis and Forecast
10.1 Introduction
10.2 Europe Biopharmaceutical CMO Services Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Biopharmaceutical CMO Services Market Size Forecast by Type
10.6.1 Biologics Manufacturing
10.6.2 Biosimilars Manufacturing
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Biopharmaceutical CMO Services Market Size Forecast by Applications
10.10.1 Clinical Manufacturing
10.10.2 Commercial Manufacturing
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Biopharmaceutical CMO Services Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Biopharmaceutical CMO Services Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Biopharmaceutical CMO Services Market Size Forecast by Type
11.6.1 Biologics Manufacturing
11.6.2 Biosimilars Manufacturing
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Biopharmaceutical CMO Services Market Size Forecast by Applications
11.10.1 Clinical Manufacturing
11.10.2 Commercial Manufacturing
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Biopharmaceutical CMO Services Analysis and Forecast
12.1 Introduction
12.2 Latin America Biopharmaceutical CMO Services Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Biopharmaceutical CMO Services Market Size Forecast by Type
12.6.1 Biologics Manufacturing
12.6.2 Biosimilars Manufacturing
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Biopharmaceutical CMO Services Market Size Forecast by Applications
12.10.1 Clinical Manufacturing
12.10.2 Commercial Manufacturing
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Biopharmaceutical CMO Services Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Biopharmaceutical CMO Services Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Biopharmaceutical CMO Services Market Size Forecast by Type
13.6.1 Biologics Manufacturing
13.6.2 Biosimilars Manufacturing
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Biopharmaceutical CMO Services Market Size Forecast by Applications
13.10.1 Clinical Manufacturing
13.10.2 Commercial Manufacturing
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biopharmaceutical CMO Services Market: Competitive Dashboard
14.2 Global Biopharmaceutical CMO Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lonza
14.3.2 Boehringer Ingelheim
14.3.3 AGC Biologics
14.3.4 Rentschler Biotechnologie
14.3.5 JRS Pharma
14.3.6 Catalent
14.3.7 Biomeva
14.3.8 Samsung BioLogics
14.3.9 AbbVie
14.3.10 Binex
14.3.11 WuXi Biologics
14.3.12 PRA Health Sciences
14.3.13 ProBioGen
14.3.14 KBI Biopharma
